On November 18, 2016, AmerisourceBergen amended its term loan, multi-currency revolving credit facility and its accounts receivable facility.

According to a related 8-K filing, Bank of America served as administrative agent for the term loan, JPMorgan served as agent for the unsecured multi-currency revolving credit facility and Bank of Tokyo-Mitsubishi New York Branch agented the accounts receivable facility.

The multi-currency revolving credit facility was amended to, among other things, extend the maturity date of the facility to November 18, 2021, increase the maximum permitted financial leverage ratio from 3.00:1.00 to 3.25:1.00 and add centaur services limited as a borrowing subsidiary. Interest on borrowings accrues at specified rates based on the company’s public debt ratings by Standard & Poor’s Ratings Services, Moody’s Investors Service and Fitch, and ranges from 70 basis points to 110 basis points over the Canadian Dealer Offered Rate, LIBOR, the Euro Overnight Rate and the Bankers Acceptance Stamping Fee, as applicable, and 0 basis points to 10 basis points over the alternate base rate and Canadian prime rate, as applicable, in each case, as determined in accordance with the provisions of the multi-currency revolving credit facility.

The term loan dated February 9, 2015 was amended and restated. The agreement made certain changes to the definitions, representations and negative covenants in the MWI term loan and the PharMEDium term loan, respectively, to conform to corresponding provisions of the multi-currency revolving credit facility.

The accounts receivable facility dated April 29, 2010 was amended to change certain terms in the agreement.